News & Blog

Latest from the Blog

  1. June 28, 2022

    New Treatment Approved for Certain Glioma Patients

    On June 22, 2022, the U.S. Food and Drug Administration (FDA) granted accelerated approval to a new treatment combination that will now be available as an option for certain brain tumor patients. The FDA approved the combination of two oral drugs called dabrafenib (brand name: Tafinlar) and trametinib (brand name: Mekinist) for the treatment of […]

    Read more | 
  2. May 27, 2022

    Guest Blog: Living with a Brain Tumor

    This Gray May, we come together to amplify the voices of the brain tumor community and highlight the extraordinary challenges and extraordinary hope that are familiar to us all. In honor of Brain Tumor Awareness Month, brain tumor survivor Kymberlee B. shares her experience and how she has coped with this devastating diagnosis.  Just before […]

    Read more | 
  3. May 20, 2022

    NBTS Program Helps Patients and Care Partners Navigate the Brain Tumor Experience

    Headshot of Mary Lovely, Patient Navigator

    In moments of crisis and uncertainty, members of the brain tumor community reach out to the National Brain Tumor Society’s Personalized Support and Navigation Program. This team empowers brain tumor patients and care partners with quality, unbiased information and resources. With more than 35 years of experience working closely with brain tumor patients and families, […]

    Read more | 
Share